Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy.
Butler CA, McMichael AJ, Honeyford K, Wright L, Logan J, Holmes J, Busby J, Hanratty CE, Yang F, Smith SJ, Murray K, Chaudhuri R, Heaney LG.
Butler CA, et al. Among authors: mcmichael aj.
ERJ Open Res. 2021 Sep 20;7(3):00273-2021. doi: 10.1183/23120541.00273-2021. eCollection 2021 Jul.
ERJ Open Res. 2021.
PMID: 34549044
Free PMC article.